Compass is still being developed and is effectively in beta. Some content and features may be incomplete, change, or not work as expected.

Content is anchored to trusted sources where available, but Compass has not yet been clinically reviewed. It provides general information rather than medical advice.

Feedback helps us identify gaps, errors, usability problems and opportunities to improve Compass over time.

How Compass is developedGive feedback

How the H1.2-FUS complex may contribute to ALS

Original source

Shuttle and stabilize: H1.2-FUS complex in amyotrophic lateral sclerosis pathogenesis.Neural Regen Res · 13 August 2025 (opens in a new tab)

Compass holds only the headline and link for this source, so the summary below is necessarily brief. Please read the original.

Related topics

A journal article titled “Shuttle and stabilize: H1.2-FUS complex in amyotrophic lateral sclerosis pathogenesis” was published in Neural Regeneration Research on August 14, 2025. The available source provides no details of the study’s findings or methods.

Why this matters

The article may be relevant to researchers studying mechanisms involved in amyotrophic lateral sclerosis (ALS), but its clinical significance cannot be assessed from the available information. No treatment or patient benefit is established.

Limitations and context

Only the title and publication metadata are available. The study design, participants or experimental models, results, and peer-review details cannot be assessed from this source record. Further information would be needed to determine what the work shows and whether it changes understanding or treatment of ALS.

Summarised by Compass 10 August 2026

This summary was generated by AI from the source listed above. It is not medical advice, so read the original source for anything that affects your care.

Bibliographic data from PubMed is courtesy of the U.S. National Library of Medicine. Compass does not reproduce source abstracts and may not reflect the most current record.

Relevant to you?